Cardiogen-82
Total Payments
$650,678
Transactions
114
Doctors
70
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $9,247 | 13 | 10 |
| 2023 | $197,844 | 42 | 27 |
| 2022 | $109,498 | 43 | 28 |
| 2021 | $235,859 | 12 | 8 |
| 2020 | $98,230 | 4 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $500,745 | 9 | 77.0% |
| Consulting Fee | $111,849 | 2 | 17.2% |
| Grant | $18,250 | 6 | 2.8% |
| Royalty or License | $14,500 | 1 | 2.2% |
| Travel and Lodging | $2,957 | 2 | 0.5% |
| Food and Beverage | $2,376 | 94 | 0.4% |
Payments by Type
Research
$500,745
9 transactions
General
$149,932
105 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| IMPACT OF CORONARY ARTERY STENTING ON QUANTITATIVE MYOCARDIAL BLOOD FLOW AND HEALTH STATUS | Bracco Diagnostics Inc. | $125,548 | 1 |
| IMPACT OF CORONARY ARTERY STENTING ON QUANTITATIVE MYOCARDIAL BLOOD FLOW AND HEALTH STATUS | BRACCO DIAGNOSTICS INC. | $125,547 | 1 |
| IIS-US-0145 | BRACCO DIAGNOSTICS INC. | $110,000 | 0 |
| Comparison of MBF and CFR measurements as calculated by HeartSee, using PET MPI data obtained with Rb-82 infused at 50 vs. 20 mL/min using the CardioGen-82 Model 1700 Infusion System | Bracco Diagnostics Inc. | $88,065 | 0 |
| Bober_The Impact of Absolute Resting Myocardial Flow and Coronary Flow Reserve on Left Ventricular Geometries, Renal Function and Death | Bracco Diagnostics Inc. | $22,230 | 0 |
| Comparison of MBF and CFR measurements as calculated by HeartSee, using PET MPI data obtained with Rb-82 infused at 50 vs. 20 mL/min using the CardioGen-82 Model 1700 Infusion System. | Bracco Diagnostics Inc. | $17,613 | 0 |
| IIS-US-0147 | Bracco Diagnostics Inc. | $11,742 | 0 |
Top Doctors Receiving Payments for Cardiogen-82 — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Cardiovascular Disease | Houston, TX | $17.35 | 1 |
| , MD | Interventional Cardiology | Pasadena, TX | $17.35 | 1 |
| , M.D | Internal Medicine | Pasadena, TX | $17.35 | 1 |
| , M.D | Interventional Cardiology | Houston, TX | $17.33 | 1 |
| , M.D | Cardiovascular Disease | Houston, TX | $17.33 | 1 |
| , M.D | Cardiovascular Disease | Houston, TX | $17.33 | 1 |
| , M.D | Cardiovascular Disease | Houston, TX | $17.33 | 1 |
| , PA-C | Physician Assistant | South Charleston, WV | $15.38 | 1 |
| , MD | Cardiovascular Disease | Jackson, MS | $15.24 | 1 |
| , MD | Cardiovascular Disease | Jackson, MS | $15.24 | 1 |
| , MD | Cardiovascular Disease | Jackson, MS | $15.24 | 1 |
| , MD, MPH | Cardiovascular Disease | Mason City, IA | $13.79 | 1 |
| , D.O | Cardiovascular Disease | Mason City, IA | $13.79 | 1 |
| , M.D | Internal Medicine | Mason City, IA | $13.79 | 1 |
| , D.O | Internal Medicine | Ukiah, CA | $13.79 | 1 |
| , M.D | Internal Medicine | Mason City, IA | $13.79 | 1 |
| , MD | Cardiovascular Disease | Tupelo, MS | $13.47 | 1 |
| , MD | Cardiovascular Disease | Tupelo, MS | $13.47 | 1 |
| , MD | Cardiovascular Disease | Tupelo, MS | $13.47 | 1 |
| , MD | Cardiovascular Disease | Tupelo, MS | $13.47 | 1 |
| , M.D | Cardiovascular Disease | New Orleans, LA | $12.88 | 1 |
Ad
Manufacturing Companies
- Bracco Diagnostics Inc. $410,999
- BRACCO DIAGNOSTICS INC. $239,679
Product Information
- Type Drug
- Total Payments $650,678
- Total Doctors 70
- Transactions 114
About Cardiogen-82
Cardiogen-82 is a drug associated with $650,678 in payments to 70 healthcare providers, recorded across 114 transactions in the CMS Open Payments database. The primary manufacturer is Bracco Diagnostics Inc..
Payment data is available from 2020 to 2024. In 2024, $9,247 was paid across 13 transactions to 10 doctors.
The most common payment nature for Cardiogen-82 is "Unspecified" ($500,745, 77.0% of total).
Cardiogen-82 is associated with 7 research studies, including "IMPACT OF CORONARY ARTERY STENTING ON QUANTITATIVE MYOCARDIAL BLOOD FLOW AND HEALTH STATUS" ($125,548).